An Australian stem cell and regenerative medicine company

September 04, 2017

Cynata Presentation at the 2017 Rodman & Renshaw Investment Conference

Please view our presentation at the 19th Annual Rodman & Renshaw Global Investment Conference

July 21, 2017

CNBC Interview With Ross Macdonald

Ross Macdonald tells CNBC about how the company has progressed to a phase 1 clinical trial

Watch Interview

July 11, 2017

Q&A With Ross Macdonald

Q&A between Cynata CEO Dr Ross Macdonald and the respected and influential industry commentator Professor Paul Knoepfler of the UC Davis School of Medicine

Read More

June 01, 2017

A brief description of some of Cynata’s activities

A brief presentation on recent activities at Cynata

May 10, 2017

Webcast Interview with UK Chief Investigator in GvHD Clinical Trial

Please listen to an interview with Dr Adrian Bloor, UK Chief Investigator in Cynata’s Phase 1 clinical trial in acute steroid resistant graft-versus-host disease (GvHD).